Trust is essential in every area of healthcare. But in oncology, the stakes are especially high.
A patient deciding whether to begin a new therapy is placing immense trust in their care team and in the evidence behind that treatment. A physician evaluating a new diagnostic tool needs to understand not only what the data shows, but also its limitations. A patient reviewing real-world evidence needs confidence that the information being presented is accurate, contextualized, and complete.
In each of these situations, communication plays a critical role. At Speaking of Science, we believe effective science communication isn’t about making the strongest possible claim. It’s about making the evidence as clear and meaningful as possible—without asking an audience to take more from the data than the data can support.
Skip the jargon
Oncology is moving quickly, with new therapeutic approaches, biomarkers, diagnostics, clinical trial results, and real-world evidence continually adding to what we know about cancer and how we treat it. For people working within the field, that pace can be challenging enough. For patients, caregivers, and other audiences without specialized expertise, the language surrounding those advances can create an additional barrier.
In other words, scientific complexity may be unavoidable, but the communication around it doesn’t need to be confusing. Clear communication lays the groundwork on which trust is built—and depending on the audience, using plain language can be more powerful than utilizing dense medical jargon.
Importantly, clarity certainly doesn’t mean stripping away every technical detail. The goal isn’t to make science sound simple; it’s to make complex science understandable. Oversimplifying complicated science can reduce the value of the information it holds. The key is to identify what an audience needs to understand, and present that information in a way that is accurate, accessible, and relevant to them.
Context = comprehension
Every scientific finding exists within a larger context. A promising clinical trial may have limitations; an impressive endpoint may be one of several outcomes being evaluated. Real-world evidence can provide valuable insights while carrying different considerations than evidence generated through a randomized controlled trial.
Transparent science communication makes room for uncertainty, limitations, and unanswered questions alongside encouraging results. That might mean explaining the size and composition of a study population, distinguishing relative from absolute risk, providing context around an endpoint, or being clear about where additional research is still needed.
It can be tempting to worry that acknowledging limitations will weaken a message. In many cases, the opposite is true. Audiences are more likely to trust communicators who give them the context they need to evaluate information for themselves.
The nuance of audience
Transparency also requires understanding who is receiving the information. A medical oncologist, a payer, a patient, and a caregiver may encounter the same clinical data, but they won’t necessarily approach those data with the same questions.
A physician may want to understand how a new therapy could fit into an existing treatment pathway. One person may be focused on outcomes and real-world value. Another may be trying to understand what a particular finding could mean for their treatment options, quality of life, or future.
Effective science communication respects those differences. That doesn’t mean changing the facts depending on the audience. It means providing the context, language, and level of detail that allow each audience to engage meaningfully with the same underlying evidence.
Credibility > clickbait
Healthcare communicators are often tasked with making information compelling. But compelling and sensational aren’t the same thing.
Terms like “breakthrough,” “game-changing,” and “revolutionary” can attract attention, but when the evidence doesn’t fully support them, they can also undermine credibility. In oncology especially, language carries weight. Behind every statistic are patients and families navigating real decisions about treatment, prognosis, and quality of life.
Respecting those audiences means resisting the temptation to overstate what research tells us. Sometimes the strongest message is also the most straightforward one: Here’s what we know. Here’s what we don’t know yet. And here’s why this finding matters.
Transparency = trust
Organizations earn credibility when their audiences can consistently expect information that is accurate, appropriately contextualized, and clear about both evidence and uncertainty. That consistency matters as science evolves.
Today’s promising finding may be refined by tomorrow’s larger study. Treatment standards change. New evidence challenges old assumptions. Communicators need to be able to acknowledge those changes without undermining confidence in the scientific process. Transparent communication helps audiences understand that evolving evidence isn’t a failure of science. It’s how science works.
At Speaking of Science, we help organizations communicate complicated science without losing the nuance that makes it credible. That means asking questions before making claims. Understanding the evidence before translating it. Recognizing what different audiences need to know. And treating patients, clinicians, payers, advocates, and other stakeholders as intelligent participants in the conversation.
In oncology, effective communication isn’t simply about getting attention. It’s about earning trust. And trust comes from showing up with clarity, transparency, and respect for the people on the other side of the message.
